CTOs on the Move

MEDZONE

www.medzone.ca

 
MEDZONE Inc. is a Montreal, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.medzone.ca
  • 9330 Boul Gouin E
    Montreal, QC CAN H1E 1C9
  • Phone: 514.648.3746

Executives

Name Title Contact Details

Similar Companies

Behaviorial Health Link

Behaviorial Health Link is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kirby Lester Inc.

Kirby Lester Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lake Forest, IL. To find more information about Kirby Lester Inc., please visit www.kirbylester.com

BluMetric

BluMetric is a new company built on a proud past. Its five originating operating companies, WESA, WESAtech, Envir-Eau, OEL-HydroSys, and Seprotech, are internationally known for cutting-edge work in the fields of water/wastewater treatment and professional environmental services. Our combined staff of approximately 170 scientists, engineers, industrial hygienists, environmental auditors, project managers, financial management specialists and support personnel are uniquely equipped to undertake environmental projects of any size, in any industry. Innovation, agility and client-responsive service are our hallmarks.

Buckeye Home Health Care

Buckeye Home Health Care is a Medicare Certified agency that provides comprehensive healthcare services by a variety of healthcare professionals in the comfort of your own home.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.